Table 3.
Univariate Analysis and Multivariate Analyses for the Positive RT-PCR test.
| Univariate Analyses | Multivariate analyses | |||
|---|---|---|---|---|
| P | OR (95% CI) | P | OR (95% CI) | |
| Management (comprehensive intervention vs. no intervention) | <0.001 | 0.152 (0.064, 0.360) | <0.0011 | 0.169 (0.070, 0.408) |
| <0.0012 | 0.169 (0.070, 0.408) | |||
| <0.0013 | 0.162 (0.066, 0.395) | |||
| <0.0014 | 0.169 (0.069, 0.412) | |||
| <0.0015 | 0.166 (0.067, 0.407) | |||
| <0.0016 | 0.165 (0.067, 0.406) | |||
| Sex (M vs. F) | 0.623 | 1.231 (0.538, 2.813) | 0.448 | 1.394 (0.592, 3.286) |
| 0.451 | 1.395 (0.587, 3.318) | |||
| 0.170 | 1.891 (0.760, 4.705) | |||
| 0.198 | 1.825 (0.730, 4.564) | |||
| 0.207 | 1.806 (0.721, 4.525) | |||
| 0.210 | 1.800 (0.718, 4.510) | |||
| Age | 0.026 | 1.040 (1.005, 1.076) | 0.127 | 1.026 (0.993, 1.062) |
| 0.129 | 1.026 (0.992, 1.062) | |||
| 0.093 | 1.030 (0.995, 1.065) | |||
| 0.189 | 1.024 (0.988, 1.062) | |||
| 0.184 | 1.025 (0.989, 1.062) | |||
| 0.183 | 1.025 (0.989, 1.062) | |||
| BMI | 0.999 | 1.000 (0.890, 1.123) | 0.988 | 0.999 (0.893, 1.118) |
| 0.913 | 0.994 (0.888, 1.112) | |||
| 0.755 | 0.981 (0.871, 1.105) | |||
| 0.716 | 0.978 (0.869, 1.102) | |||
| 0.704 | 0.977 (0.868, 1.101) | |||
| Smoking Status (Y vs N) | 0.998 | NA* | 0.997 | NA |
| 0.997 | NA | |||
| 0.997 | NA | |||
| 0.997 | NA | |||
| Alcohol Use (Y vs. N) | 0.725 | 0.766 (0.174, 3.374) | 0.951 | 0.951 (0.188, 4.804) |
| 0.998 | 0.998 (0.197, 5.051) | |||
| 0.958 | 1.045 (0.206, 5.309) | |||
| 0.946 | 1.058 (0.208, 5.373) | |||
*Estimators were not available because one cell contained zero value.
1Model included site, age and sex.
2Model included site, age, sex and BMI.
3Model included site, age, sex, BMI, smoking status and alcohol use.
4Model included site, age, sex, BMI, smoking status, alcohol use and disease history.
5Model included site, age, sex, BMI, smoking status, alcohol use, disease history and symptoms status when entering isolation site.
6Model included site, age, sex, BMI, smoking status, alcohol use, disease history, symptoms status when entering isolation site, and the duration from initial symptoms onset to nucleic retest.